Literature DB >> 6131528

[Treatment of algodystrophies].

B Delcambre, B Duquesnoy, G Baudens, P Cocheteux, A Thevenon, J M Delfosse, F Pouyol.   

Abstract

The first part of the article is a general review of the various drug treatments available for algodystrophy : purely symptomatic, analgesic treatment, vaso-active drugs, calcitonin. The major advance over the last few years has been the use of beta-blockers and calcitonin but, to date, only one double blind trial has been published. This study demonstrated the value of calcitonin after one month of treatment. The authors undertook a retrospective study of 651 cases and a prospective study of 91 cases and based their work on the evaluation of various treatments prescribed separately examining each therapeutic sequence rather than each individual case. Three treatments stood out by their frequent use : griseofulvin, calcitonin and beta-blockers. Each of these drugs was effective in more than 60 p. cent of cases. It is impossible, in such a study, to formulate a hierarchy of the various treatments. Only controlled studies will be able to establish their order of effectiveness. The results vary somewhat according to the site of the algodystrophy. The best therapeutic response is obtained in lesions involving the hip leading to a very favourable prognosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6131528

Source DB:  PubMed          Journal:  Rev Rhum Mal Osteoartic        ISSN: 0035-2659


  5 in total

1.  Treatment of severe, recalcitrant reflex sympathetic dystrophy: assessment of efficacy and safety of the second generation bisphosphonate pamidronate.

Authors:  B Cortet; R M Flipo; P Coquerelle; B Duquesnoy; B Delcambre
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

2.  Regional intravenous guanethidine blocks in algodystrophy.

Authors:  F Eulry; D Lechevalier; B Pats; C Alliaume; P Crozes; P Vasseur; G Coutant; D Felten; S Pattin
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

3.  Reflex sympathetic dystrophy: an underreported syndrome in children?

Authors:  R A Lemahieu; C Van Laere; L A Verbruggen
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

4.  [Sudeck's disease--its clinical picture and therapy].

Authors:  R Kissling; M Sager
Journal:  Unfallchirurgie       Date:  1990-04

5.  Scintigraphic evaluation of reflex sympathetic dystrophy: comparative study of the course of the disease under two therapeutic regimens.

Authors:  H Rico; E Merono; F Gomez-Castresana; J Torrubiano; D Espinos; P Diaz
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.